Xoft, Inc.

the xoft® electronic brachytherapy system® is an isotope-free radiation treatment cleared by the fda for use anywhere in the body, including for the treatment of early stage breast cancer, endometrial cancer and skin cancer. it utilizes a proprietary miniaturized x-ray as the radiation source that delivers precise treatment directly to cancerous areas while sparing healthy tissue and organs. the xoft system can be administered as a single course of radiation therapy during surgery in the form of intraoperative radiation therapy (iort) or in the form of partial breast irradiation (apbi). the xoft system does not require a shielded environment and the system’s relatively small size and mobility enable it to be used in virtually any clinical setting. a post-market study is underway to assess the safety and efficacy of iort with the xoft system. xoft, inc. is a wholly owned subsidiary of icad, inc. for more information about xoft visit www.xoftinc.com.